Daily News and Tips
Top promoted drugs are less likely than top selling and top prescribed drugs to be effective, safe, affordable, novel, and represent a genuine advance in treating a disease, argue US researchers in The BMJ today.
PARIS Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults…
(Reuters) – French drugmaker Sanofi said on Tuesday it was committing up to $2.17 billion to a collaboration with its…
A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron’s experimental drug to…